Literature DB >> 7468548

Shigella sepsis.

B Duncan, V A Fulginiti, O F Sieber, K J Ryan.   

Abstract

It is generally believed that bacteremia rarely occurs with enteric Shigella infections. During a five-year period, 110 children were admitted to the University Hospital of the Arizona Health Sciences Center, Tucson, with Shigella enteritis. Eight (7%) had Shigella bacteremia/septicemia, and four of the eight died. An analysis of these patients and their course disclosed clinical characteristics that were of potential prognostic importance. Some of these indicators are identifiable early and hence could be useful in management. The patients at greatest risk were afebrile; 10% or more dehydrated; malnourished, with a low serum albumin level; infected with ampicillin-resistant strains; had leukopenia during the course of the illness; and had persistent watery hemoglobin-positive stools.

Entities:  

Mesh:

Year:  1981        PMID: 7468548     DOI: 10.1001/archpedi.1981.02130260043013

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  4 in total

1.  Four cases of Shigella septicemia in Israel.

Authors:  M Alkan; E Salzstein; A Simu
Journal:  Eur J Clin Microbiol       Date:  1985-08       Impact factor: 3.267

Review 2.  Shigellemia in AIDS patients: case report and review of the literature.

Authors:  J Huebner; W Czerwenka; E Gruner; A von Graevenitz
Journal:  Infection       Date:  1993 Mar-Apr       Impact factor: 3.553

3.  An O antigen capsule modulates bacterial pathogenesis in Shigella sonnei.

Authors:  Mariaelena Caboni; Thierry Pédron; Omar Rossi; David Goulding; Derek Pickard; Francesco Citiulo; Calman A MacLennan; Gordon Dougan; Nicholas R Thomson; Allan Saul; Philippe J Sansonetti; Christiane Gerke
Journal:  PLoS Pathog       Date:  2015-03-20       Impact factor: 6.823

Review 4.  Enteric infectious disease in neonates. Epidemiology, pathogenesis, and a practical approach to evaluation and therapy.

Authors:  J S Kinney; J J Eiden
Journal:  Clin Perinatol       Date:  1994-06       Impact factor: 3.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.